According to the American Migraine Foundation, migraine affects 1 in 4 households in the US, and over 1 billion people worldwide live with migraine.
While there is no cure for migraine, pharmaceutical companies continue to innovate to provide treatment options for patients suffering from migraine.
It is an exciting time for migraine treatment.
Since 2018, ten new products have become available for migraine treatment. New therapies include new classes of drugs, such as calcitonin gene-related peptide (CGRP) monoclonal antibodies and CGRP-targeting gepants.
Related Insights & Outlooks
Q3-2024 Top Pharma Earnings Results
•
November 18, 2024
From breakthrough therapies to strategic market maneuvers, here’s how the Top 15 Pharma Companies navigated the quarter’s challenges and opportunities.
Q2-2024 Top Pharma Earnings Results
•
August 14, 2024
The pharmaceutical industry showed impressive performance in Q2 2024, with a notable focus on innovation and expansion.
.avif)